Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali

BACKGROUND: The Large-scale Assessment of the Key health-promoting Activities of two New mass drug administration regimens with Azithromycin (LAKANA) trial in Mali aims to evaluate the efficacy and safety of azithromycin (AZI) mass drug administration (MDA) to 1–11-month-old infants as well as the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Luoma, Juho, Adubra, Laura, Alber, Dagmar, Ashorn, Per, Ashorn, Ulla, Cloutman-Green, Elaine, Diallo, Fatoumata, Ducker, Camilla, Elovainio, Riku, Fan, Yue-Mei, Gates, Lily, Gruffudd, Gwydion, Haapaniemi, Tiia, Haidara, Fadima, Hallamaa, Lotta, Ihamuotila, Rikhard, Klein, Nigel, Martell, Owen, Sow, Samba, Vehmasto, Taru, Cheung, Yin Bun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648361/
https://www.ncbi.nlm.nih.gov/pubmed/37968741
http://dx.doi.org/10.1186/s13063-023-07771-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648361/
https://www.ncbi.nlm.nih.gov/pubmed/37968741
http://dx.doi.org/10.1186/s13063-023-07771-6

Ejemplares similares